medigraphic.com
ISSN 2448-8720 (Print)
Organo Oficial de la Secretaria de Salud de Quintana Roo

2016, Number 33

<< Back Next >>

Salud Quintana Roo 2016; 9 (33)

Thyroid cancer: Clinical characterization and consistency of diagnostic tests

Vidaurri-Ojeda AC, Gómez-Hernández J, Chávez-Hernández MM, González-Fondón A, Jiménez-Báez MV

Language: Spanish
References: 22
Page: 11-17
PDF size: 249.38 Kb.


ABSTRACT

Introduction: Thyroid cancer has a prevalence of 10% in head and neck tumors. The objective of the study was to identify thyroid cancer epidemiological characteristics in patients undergoing thyroid surgery and compared according to their histological type, and determine the agreement between diagnostic tests.
Material and methods: A cross-sectional study, patients undergoing thyroid surgery from 2010 to 2013 in a secondary hospital with definitive histopathological result of thyroid cancer were included. Clinical data, diagnostic methods, pathology and evolution were recorded. They were classified according to TNM (tumor-lymph node-metastasis) and recurrence was determined. Comparing the characteristics according to the histology was performed.
Results: Forty four cases of thyroid cancer were reported in the study period undergoing surgery; average age of 44 years, 93% were women; according to their lineage histology 77,2% was papillary carcinoma, follicular 18,8%, 2,2% and 2,2% undifferentiated mixed. Moderate agreement between diagnostic tests. (ὠ =0.64).
Conclusions: The frequency of thyroid cancer according to their histological type in our study is similar to what was published. Diagnostic tests have a moderate agreement for the diagnosis of thyroid cancer.


REFERENCES

  1. Secretaría de salud. Subsecretaría de prevención y promoción de la salud. Dirección general de epidemiología. [En línea] Perfil epidemiológico de los tumores malignos en México. Consultado el 04 Marzo 2016. [Disponible en]: www.dgepi.salud.gob.mx

  2. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, and Vigneri R. Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors. Journal of Cancer Epidemiology. 2013;5(3):14-25.

  3. Turtle M, Ball D, Dickson P et al. [En línea]: National Comprehensive Cancer Network Guidelines Thyroid Carcinoma. Version 2. 2013. Consultado el 04 marzo 2016. [Disponible en]: http://www.klinikum.uni-muenchen. de/Schilddruesenzentrum/download/inhalt/Leitlinien/NCCN/Leitlinien_ NCCN_2013_.pdf

  4. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, et al. [En línea] SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, based on November 2012 SEER data submission, posted to the SEER web site, 2013. Consultado el 04 marzo 2016. [Disponible en]: http://seer.cancer.gov/csr/1975_2010/,

  5. Hop S. Tran Cao, MD, Lily E. Johnston, BS, David C. Chang, PhD, and Michael Bouvet, MD. A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry. Surgery. 2012; 152(2):145-51.

  6. Villegas SAA, Hurtado LLM, Zaldivar RFR, Basurto KE, Muñoz SO, Pulido CA et al.Epidemiología del Nódulo Tiroideo. Cirujano General.2001; 23(4):283-285.

  7. Dadu R, Ahn P, Christopher H, Holsinger C, Hu C. Thyroid and Parathyroid Cancers. J Clin Endocrinol Metabol 2013, 98:E364E369.

  8. Miller M. The Patient with a Thyroid Nodule. Med Clin N Am. 2010; 94(5): 1003–1015.

  9. Cooper D, Doherty G, Haugen B, Kloos R, Lee S, Mandel S et al. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2009; 19(11):1167-1214.

  10. López-López JA, Hurtado-López LM, Zaldivar-Ramírez RF. Frecuencia de la patología quirúrgica tiroidea. Rev Med Hosp Gen Mex 2001; 64 (3): 137-142.

  11. Castro R, Espiritu R, Bahn R. Predictors of Malignancy in Patients with Cytologically Suspicious Thyroid Nodules. Thyroid; 21(11):1191-8.

  12. Bongiovanni M, Spitale A, Faquin F, Mazzucchelli L, Baloch Z. The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis. Acta Cytologica 2012;56:333–339.

  13. Cibas E, Ali S. The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 2009;132:658-665.

  14. Ohori P, Schoedel K. Thyroid Cytology: Challenges in the Pursuit of Low- Grade Malignancies. Radiol Clin N Am 2011; 49:435–451.

  15. Flores-Ortega A, Rivera-López E, Guillén-González M, Vergara-López A. Cáncer de tiroides: Revisión de casos del Centro Médico Nacional «20 de Noviembre». Revista de Endocrinología y Nutrición, 2010. ¿ 18(1): 11-17.

  16. Gosnell J, Clark O. Surgical Approaches to Thyroid Tumors. Endocrinol Metab Clin N Am. 2008. 37:437– 455.

  17. Kendall, M.G. 1938. A new measure of rank correlation. Biometrika, 30: 81-93.

  18. Badii M.H., Guillen A, Lugo O.P, Aguilar J.J. Correlación No-Paramétrica y su Aplicación en la Investigaciones Científica. Daena: International Journal of Good Conscience. 9(2):31-40.

  19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977; 33:159-74.

  20. Rizwan A, Steward D. Surgical Management of Thyroid Disease. Otolaryngol Clin N Am, 2010. 43:273–283.

  21. Sociedad Mexicana de Nutrición y Endocrinología. Guía Clínica para el Diagnóstico y Tratamiento del Cáncer Diferenciado de Tiroides. [En línea]. Consultado el 04 marzo 2016. [Disponible en]: www.endocrinologia.org.mx/ v2/paginas/concenso.php

  22. Kitamura Y, Shimizu K, Nagahama M. Immediate Causes of Death in Thyroid Carcinoma: Clinicopathological Analysis of 161 Fatal Cases. J Clin Endocrinol Metab. 1999; 84(11):4043-9.




2020     |     www.medigraphic.com